Sotkamo Silver — Self-funded operational recovery

Sotkamo Silver (NGM: SOSI)

Last close As at 10/08/2026

SEK4.74

0.17 (3.62%)

Market capitalisation

SEK1,607m

More on this equity

Research: Metals & Mining

Sotkamo Silver — Self-funded operational recovery

Sotkamo Silver’s Q2 results provide further evidence that its operational reset is gaining traction. Record net sales of SEK198m and EBITDA of SEK86m were supported by higher volumes and strong metal prices, despite a lower silver grade. Operating cash flow of SEK94m funded accelerated mine development and increased cash to SEK141m. With grades expected to recover in H2 and the balance sheet now able to support self-funded growth, the double-digit valuation discount to peers suggests that the market does not fully reflect the improving operating profile.

Written by

Andrey Litvin

Energy and Resources Analyst

Metals and mining

QuickView

11 August 2026

Price SEK4.72
Market cap SEK1,607m
Price Performance
Share details
Code SOSI
Listing NGM

Shares in issue

340.5m

Net cash/(debt) at H126

SEK(52.5)m

Business description

Sotkamo Silver is a mining and ore exploration company that develops and utilises mineral deposits in the Kainuu region in Finland.

Bull points

  • Grade, volume and resource growth.
  • Strong free cash flow generation.
  • Valuation discount to silver peers.

Bear points

  • High sensitivity to the silver price.
  • Production ramp-up execution risk.
  • Single-mine exposure.

Analyst

Andrey Litvin
+44 (0)20 3077 5700

EDISON QUICKVIEWS ARE NORMALLY ONE-OFF PUBLICATIONS WITH NO COMMITMENT TO WRITING ANY FOLLOW UP. QUICKVIEW NOTES USE CONSENSUS EARNINGS ESTIMATES.

Throughput gains support H2 production growth

Mill feed increased by 33% q-o-q and 36% y-o-y to 148kt, lifting silver production by 8% sequentially to 218koz despite the head grade declining to 56g/t. H1 silver production of 419koz represented 35–47% of unchanged FY26 guidance of 0.9–1.2Moz. Management expects grades to increase to 80–90g/t as mining moves towards deeper underground areas. Maintaining throughput close to the Q2 level while delivering the planned grade recovery would move production towards the middle of guidance and establish a stronger operating base for the medium-term target of 1.4Moz of annual silver production.

Cash generation funds accelerated development

Operating cash flow reached SEK94m in Q2 and SEK170m in H1, compared with capex of SEK22m and SEK37m, respectively. Cash increased by SEK127m from year-end to SEK141m, while net debt fell to c SEK53m and net debt/EBITDA declined to 0.2x. This will allow Sotkamo to accelerate underground development, infill drilling and exploration without relying on additional financing. The post-period conversion of €2.0m of Business Finland debt into a grant further strengthens the balance sheet as the company prepares additional mining areas and advances work to extend the resource base and mine life.

Valuation: Low multiples despite growth momentum

The shares trade on consensus FY26e EV/EBITDA and P/E multiples of 3.5x and 4.4x, respectively, based on estimates from a single analyst, representing double-digit discounts to independent primary silver producers. Silver has recently recovered to c US$64/oz, while consensus expectations remain supportive at US$72.0/oz in 2026, declining to US$68.5/oz in 2027 and US$60.0/oz in 2028. Higher production and head grades, together with exploration work aimed at expanding the mineral resource base and extending the mine life, should support Sotkamo’s earnings growth and provide scope for the valuation discount to narrow.

Source: Bloomberg. Note: Consensus expectations are based on a single analyst.

Consensus estimates

Year end Revenue (SEKm) EBITDA (SEKm) PBT (SEKm) EPS (SEK) P/E (x)
12/24 412.2 109.1 (2.3) (0.06) N/A
12/25 393.0 80.0 (53.0) (0.16) N/A
12/26e 816.0 474.0 364.0 1.08 4.4
12/27e 807.0 453.0 401.0 1.00 4.7

Q226: Record sales and strong cash conversion

Sotkamo’s net sales increased by 6% q-o-q to a record SEK198m as higher volumes offset a lower silver price versus Q126. The Q226 silver price averaged US$73.1/oz, compared with an H126 average of US$78.8/oz, and the quarter-end price of US$58.8/oz. Silver hedging contributed SEK5m to quarterly revenue, with the company’s one-month hedging and settlement horizon resulting in a limited delay between spot-price movements and reported revenue.

EBITDA declined by 13% q-o-q to SEK86m and the margin narrowed from 53% to 43%. This reflected the lower silver price, increased underground mining activity and a slight rise in unit costs. Supplies and services increased to SEK88m from approximately SEK66m in Q126, partly due to drift development and stope preparation undertaken to support future production. Despite the sequential reduction, the Q226 EBITDA margin remained well above the company’s medium-term target of more than 30%.

EBIT was SEK73m, while net income reached SEK48m, equivalent to SEK0.14 per share. H126 earnings below the operating line were affected by non-cash convertible accounting, with financial expenses of SEK90m including a SEK78m adverse fair-value movement in conversion option liabilities. This had no corresponding effect on the company’s strong cash generation: operating cash flow reached SEK94m in Q226 and SEK170m in H126, with capex outflows of SEK22m and SEK37m, respectively. Cash increased by SEK66m during the quarter and by SEK127m from year-end to SEK141m, while net debt fell to c SEK53m from c SEK200m at end-2025 and net debt/EBITDA declined to 0.2x.

Higher throughput lifts silver production and reduces sequential unit costs

Mill feed increased by 33% q-o-q and 36% y-o-y to 148kt, supporting silver production of 218koz, up 8% from 201koz in Q126 and 16% from 187koz in Q225. H1 silver production reached 419koz, 18% above the prior-year period. Higher throughput more than offset the decline in the silver head grade to 56g/t from 70g/t in Q126 and 65g/t a year earlier. The lower grade reflected the use of open-pit ore to supplement underground production while mine development was accelerated, as well as the processing of stopes with a higher contribution from gold.

Gold production increased to 996oz from 783oz in Q126 and 417oz in Q225, taking H126 output to 1,779oz, more than double the prior-year level. Lead production increased to 172t from 145t in Q126 and 144t a year earlier. Zinc output recovered to 345t from 307t in Q126, although it remained below the 370t produced in Q225.

In the absence of disclosed realised prices and revenue for gold, lead and zinc, a conventional silver cash-cost calculation after by-product credits is not possible. We therefore assess unit-cost development using reported cash operating expenses per tonne milled. Cash operating expenses increased by 27% q-o-q to SEK119m, below the 33% increase in throughput, reducing the implied cost by 5% to approximately SEK803/t from SEK842/t in Q126. This remained 12% above the SEK714/t recorded in Q225, consistent with higher underground mining costs and a slight increase in unit costs. Part of the expenditure related to drift development and stope preparation intended to support future production.

The higher Q226 throughput provides a stronger production base for H226, when silver grades are expected to improve as mining shifts towards deeper underground areas. This should support a further increase in silver output during the remainder of the year.

Guidance maintained as focus shifts to grade recovery and production growth

Sotkamo maintained its revised 2026 guidance for silver production of 0.9–1.2Moz, EBITDA above €33m and year-end net debt/EBITDA below 0.1x. H126 silver production of 419koz represented 35–47% of the full-year range, while consensus FY26e revenue of SEK816m and EBITDA of SEK474m imply increases of 108% and 493% from FY25, respectively, reflecting the combined effect of stronger metal prices and the anticipated operational recovery. H126 EBITDA of SEK185m represents 39% of the full-year forecast, leaving a material H226 step-up that should be supported by higher grades and production.

Management expects silver grades to increase to 80–90g/t from 56g/t in Q226 as mining moves towards deeper underground areas. This should be supported by the completed contractor ramp-up, accelerated mine development and preparation of additional mining areas. Maintaining throughput close to the Q2 level while delivering the planned grade recovery would move production towards the middle of guidance and provide a stronger operating base for the company’s medium-term target of 1.4Moz of annual silver production. Infill drilling to 700m and further investigation of the West mineralisation offer further potential for resource conversion, new mining areas and mine-life extension.

The silver price has recovered to c US$64/oz from US$58.8/oz at the end of Q226, although it remains below the Q226 average of US$73.1/oz. The company estimates that each US$1/oz movement changes annual revenue by approximately SEK9m. Higher grades and production should therefore provide an important operational offset if silver prices remain below H126 levels. The broader industry backdrop also remains supportive, with the global silver market expected to record a sixth consecutive annual deficit in 2026, according to the Silver Institute. The balance sheet target appears increasingly achievable following the H1 cash build, strong free cash flow and subsequent conversion of €2.0m of Business Finland debt into a grant. Overall, Sotkamo appears to be moving from operational stabilisation towards self-funded production growth, resource expansion and mine-life extension.

Valuation: Low multiples despite strong operational momentum

The shares trade on consensus FY26e EV/EBITDA and P/E multiples of 3.5x and 4.4x, respectively, based on estimates from a single analyst, representing double-digit discounts to independent primary silver producers. The modest expansion in FY27e multiples reflects a slight decline in consensus EBITDA and EPS, consistent with lower silver price assumptions being partly offset by higher grades and production. Consensus silver price forecasts remain supportive at US$72.0/oz in 2026, declining to US$68.5/oz in 2027 and US$60.0/oz in 2028. The expected production ramp-up and grade recovery, together with exploration work aimed at expanding the mineral resource base and extending the mine life, should support earnings as silver prices moderate. Sustained delivery at higher production levels would also provide scope for the valuation discount to narrow.

General disclaimer and copyright

This report has been prepared and issued by Edison. Edison Investment Research standard fees are £60,000 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright 2026 Edison Investment Research Limited (Edison).

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or sol icitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

London │ New York │ Frankfurt

20 Red Lion Street

London, WC1R 4PS

United Kingdom

More on Sotkamo Silver

View All

Metals & Mining

Sotkamo Silver — Self-funded operational recovery

Latest from the Metals & Mining sector

View All Metals & Mining content

Research: Healthcare

Immix Biopharma — Q226: funded to execute its CAR-T strategy

Immix Biopharma has reported its financial results for Q226, reflecting another period of sustained progress for the lead programme, NXC-201 in relapsed/refractory amyloid light chain amyloidosis (r/r ALA). With positive interim data, in terms of both safety and efficacy, recently reported for the first 20 evaluable patients in the US-based, potentially registrational NEXICART-2 trial, all eyes now turn to the final readout from all 45 patients, guided for September 2026, a key inflection point for investor attention. Should the results be supportive, a biologics licence application (BLA) to the FDA is planned for H127, supported by one-year follow-up data from March 2027. Immix has recently strengthened its cash position through an equity raise, generating $140.7m in net proceeds, expected to support ongoing clinical development activities, working capital and general corporate purposes. Following the Q226 results, our valuation stands at $944.6m or $13.2 per share ($786.7m or $14.5 per share previously).

Continue Reading
Cancer cells low poly blue
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.